Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis.
about
Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.Predicting neutropenia risk in patients with cancer using electronic data.Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial.Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropeniaRetrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients.Pharmacoeconomic effect of compliance with pharmacist's intervention based on cancer chemotherapy regimens: a cohort study.How Effective is the Treatment of Locally Advanced and Metastatic Breast Cancer in Developing Centres?: A Retrospective Review.Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancerProof of Concept of a Mobile Health Short Message Service Text Message Intervention That Promotes Adherence to Oral Anticancer Agent Medications: A Randomized Controlled TrialAssociation of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer.Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical center.Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer - a population-based study.The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.Tolerability of a rapid-escalation vinblastine-prednisolone protocol in dogs with mast cell tumoursA phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer.Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study.Impact of Pretreatment Neutrophil Count on Chemotherapy Administration and Toxicity in Dogs with Lymphoma Treated with CHOP Chemotherapy.Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients.A Phase IV Clinical Trial of Patients with Solid Tumors Receiving Lenograstim as Primary Prophylaxis for Chemotherapy-Induced Neutropenia, in a Docetaxel-Based Regimen
P2860
Q30313786-027C7700-6B43-49B6-BCFC-24D4E4AA5A59Q31131362-1616D50B-43A8-4489-8575-17BCB5C38FDFQ33844469-1E56F54C-D0FD-40ED-A246-AB43D5100709Q34403621-0D50E71C-4B1F-4EA8-B83F-DB1AAD199B81Q35176826-737ECE29-2A9A-4ADA-86A0-222706AB6639Q36507866-9A070C51-F26C-411E-BE68-C78B9E61F437Q36605309-01549336-F19F-4EBA-B5AB-79849613826AQ36814437-61B7B21D-1B56-4F27-8842-2B5ABCF2BABBQ36966506-273E391A-7B89-4B31-9B30-84365C3DF5ECQ38636006-88677336-021A-4306-A875-50A523BDF9C8Q38757690-E9F1E3DF-F81D-406B-BC5A-D5CD8E35C262Q38812454-8FEB98D5-5D2B-450A-B1A4-F48D7A7C3D42Q40831081-6A2C97E2-6519-4248-97DE-CF535DE51B53Q42674196-10CBF500-3271-4F5F-B218-399408A338E7Q42682705-67F5AD8E-7D5F-40C8-9AD9-57B7C83BB802Q46138064-10733759-F6E0-4732-8FE0-F325ECCE378EQ47260008-CF6DCD10-4A5A-4358-805A-8263DF322BF2Q48179867-17940FD2-6C58-44E9-976D-79CA7115588EQ49784365-1E7A9F3F-DB1E-4C2C-86D2-FEAD791BB306Q59050832-B7863645-1644-4FC6-B9C1-CA8033EAEA9B
P2860
Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluating the impact of Relat ...... ast cancer- a pooled analysis.
@ast
Evaluating the impact of Relat ...... ast cancer- a pooled analysis.
@en
Evaluating the impact of Relative Total Dose Intensity
@nl
type
label
Evaluating the impact of Relat ...... ast cancer- a pooled analysis.
@ast
Evaluating the impact of Relat ...... ast cancer- a pooled analysis.
@en
Evaluating the impact of Relative Total Dose Intensity
@nl
prefLabel
Evaluating the impact of Relat ...... ast cancer- a pooled analysis.
@ast
Evaluating the impact of Relat ...... ast cancer- a pooled analysis.
@en
Evaluating the impact of Relative Total Dose Intensity
@nl
P2093
P2860
P50
P356
P1433
P1476
Evaluating the impact of Relat ...... ast cancer- a pooled analysis.
@en
P2093
Christoph Zielinski
Hans Joachim Lück
Thomas Brodowicz
Tomas Skacel
P2860
P2888
P356
10.1186/1471-2407-11-131
P407
P577
2011-04-12T00:00:00Z
P5875
P6179
1025745278